Pharmacolog i Uppsala AB (publ) announces today that the annual report for the financial year 2023 has been published.
The annual report is attached as a PDF and is available on the company’s website:
https://pharmacolog.com/investor-relations-2/financial-reports/ (Swedish only).
For more information contact:
Lars Gusch, CEO
Email: lars.gusch@pharmacolog.com
Phone: +46 70-223 97 72
About Pharmacolog
Pharmacolog (proposed name change to Perpetua Medical AB (publ)) is a medical technology company, headquartered in Uppsala, Sweden. The company’s shares (ticker PHLOG B) are traded on Nasdaq First North Stockholm.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, WasteLog™and Pharmacolog Dashboard™.
Further information regarding the company is available at https://pharmacolog.com/.
The company’s Certified Adviser is Mangold Fondkommission AB.
AR_2023 final_signed-merged